Schranz Jennifer 4
4 · Nabriva Therapeutics plc · Filed Feb 2, 2021
Insider Transaction Report
Form 4
Schranz Jennifer
Chief Medical Officer
Transactions
- Award
Ordinary Shares
2021-01-29+22,500→ 39,194 total - Tax Payment
Ordinary Shares
2021-01-31$2.62/sh−36$94→ 39,158 total